BNET Industries
Market Cap:$12.3B
Last Fiscal Year Sales:$3.7B
- Public
- US
Dow Jones Description
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn., St. Jude Medical employs approximately 14,000 people worldwide and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, electrophysiology catheters, mapping and visualization systems, vascular closure devices, heart valve replacement and repair products, and neurostimulation devices.
Number of Employees 14,000
Peer Companies
NAICS Code Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
Recent Events
-
St. Jude Medical Gets FDA Nod For Penta Surgical Lead To Manage Chronic Pain -...
-
SJM Releases New Neurostimulator Programming Software
-
Morgan Joseph Initiates Coverage on St. Jude Medical STJ with a Buy; High-Quality Name in...
-
UPDATE: St. Jude Leaves Trade Group AdvaMed In Tax Dispute
-
Zacks Analyst Blog Highlights: Morgan Stanley, Goldman Sachs, St.
-
Was the St. Jude sell-off overdone?
-
Canaccord Adams Downgrades St. Jude Medical Inc. STJ to Hold
-
David Moenning's Daily State of the Markets: Voting With Their Feet
-
Edwards Lifesciences Q3 Profit More Than Doubles; Updates FY09 Outlook
-
Uncertainty in face of reform
-
St. Jude Medical Announces Australian Launch of Devices that Diagnose and Treat Abnormal Heart Rhythms
-
Zacks Analyst Blog Highlights: Fannie Mae, Freddie Mac, St. Jude Medical, Medtronic and Boston...
-
Micell gets investment from St. Jude Medical
-
$15 million infusion for Micell
-
St. Jude Medical to Showcase Complete Cardiovascular Access, Intervention and Hemostasis...
-
FDA clears St. Jude cardiac mapping system
-
St. Jude Medical Announces European Launch of New Version of
-
St. Jude Medical Announces European Launch of New Version of Remote Patient Care Network
-
Notable Analyst Rating Changes 8/26: STJ, GMR, KMT, CP Upgraded; BKC, AMED, MDAS Downgraded
News & Analysis
Filter by
clinical trial and st. jude medical inc. - All News and Analysis
St. Jude Medical Announces First Clinical Trial Implant of Trifecta Stented Tissue Heart Valve
- 2007-07-24
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced the first patient implant in its clinical trial of Trifecta[TM], a new investigational stented, pericardial tissue heart valve.
Clinical Trial Shows Device Optimizes Cardiac Resynchronization Therapy in Less Than Two Minutes; St. Jude Medical Announces QuickOpt Optimization Clinical Trial Results and European Regulatory Approvals at Cardiostim 2006
- 2006-06-16
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced the clinical trial results, receipt of European CE Mark approval and European market launch of its QuickOptTM Timing Cycle Optimization. The trial results were presented by James G. Porterfield, M.D., principal investigator in the trial conducted under a U.S....
First Patient Enrolled in St. Jude Medical's Migraine Headache Study; Clinical Trial to Explore Link between Common Heart Defect and Migraine Headaches
- 2006-03-02
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced the enrollment of the first patient in its ESCAPE (Effect of Septal Closure of Atrial PFO on Events of Migraine with PremereTM) migraine trial.
Clinical Trial Demonstrates Device Is Effective in Treating Condition Associated with 200,000 Strokes Annually; New Device from St. Jude Medical Closes Heart Defect, Preventing Unfiltered Blood from Entering Circulation
- 2005-10-19
WASHINGTON -- Data from a clinical trial show that a new device from St. Jude Medical, Inc., (NYSE:STJ) is effective in treating a common condition associated with more than 200,000 strokes worldwide each year. The PFO patent foramen ovale CLOSE UP (Closure Using PremereTM) Trial results were presented this week...
Clinical Trial Demonstrates Positive Results for St. Jude Medical Device Treating Coronary Bypass Graft Blockages
- 2005-10-18
WASHINGTON -- Data from a key clinical trial show that a new embolic protection device from St. Jude Medical, Inc. (NYSE:STJ) has demonstrated positive results for treating patients with saphenous vein coronary bypass grafts. The trial results were presented today during a Late Breaking Clinical session at the Cardiovascular Research...
St. Jude Medical to Showcase its Most Advanced Cardiac Technology and Present Important Clinical Trial Updates at Heart Rhythm 2004
- 2004-05-17
Business Editors/Health/Medical Writers
- 1
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
Glass Door
St. Jude Medical
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Beware of The Incredible Shrinking Insurance Benefit 2 votes
